Form 4 for INSM INSMED Inc
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-13 · accession 0001628280-24-040523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-13 | INSM | Smith Michael Alexander | CLO | M - OptEx | $22.76 | +7,000 | 95.7K | +8% | +$159.3K |
| DM | 2024-09-16 | 2024-09-13 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $74.35 | -27.9K | 76.9K | -27% | -$2.07M |
| D | 2024-09-16 | 2024-09-13 | INSM | Smith Michael Alexander | CLO | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-13 | M | A | 7,000 | $22.76 | 95,727 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-13 | S | D | 9,000 | $74.75 | 67,856 | D | — | — | (F3) This is the weighted average sales price representing 9,000 shares sold at prices ranging from $74.61 to $74.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2024-09-13 | S | D | 18,871 | $74.16 | 76,856 | D | — | — | (F2) This is the weighted average sales price representing 18,871 shares sold at prices ranging from $73.61 to $74.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 7,000 | $0.00 | 0 | D | $22.76 · — to 2025-05-21 | 7,000 Common Stock | (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |